KJT Welcomes Laura McCormick, PhD

KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of Medical and Scientific Communications. Laura brings with her an impressive 24 years of biopharmaceutical experience, having made significant contributions in the fields of Medical Affairs, Medical Education, and Scientific Communications.

Laura holds a PhD in Molecular Biology and Immunology, and her career has been marked by extensive consulting work with major pharmaceutical companies. Her expertise includes guiding the publication process, shaping corporate policy, and overseeing the quality and accuracy of scientific content. Additionally, she has been instrumental in developing medical communications strategies for products across a variety of therapeutic areas.

“We are thrilled to have Laura join our team,” said Nicole Garberg, Head of Real World Evidence. “Her deep expertise and vast experience in the biopharmaceutical industry, particularly in medical and scientific communications, will be invaluable as we continue to expand our services and deliver high-quality insights to our clients.”

Throughout her career Laura has demonstrated a profound understanding of the complexities of the pharmaceutical landscape and has been a trusted advisor in the development and execution of communication strategies that resonate with scientific and medical communities, patients, and industry partners. Laura’s appointment underscores KJT’s commitment to enhancing its expertise and capabilities in the real world evidence sector, ensuring that clients receive the most informed and strategic guidance for their medical communication needs.

Blogs & News

Read More
healthcare provider using generative AI tools
Read More

Using Generative AI for Patient-Centered Market Research – Reality or Myth? 

No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…

Read More
Read More

3 Reasons Why Working in an ESOP Company is Inspiring

When I first came to the United States from Scotland, I wasn’t fully familiar with the idea of…

Read More
Read More

Finding the Path to Your Brand’s North Star: The Importance of Enhancing Brand Equity & Tracking Research

In the competitive pharmaceutical and biotech landscapes, the strength of a brand can often be the…

Read More
Read More

KJT Welcomes Melissa Usseglio, Senior Vice President of Client Strategy

KJT is thrilled to announce the hiring of Melissa Usseglio as Senior Vice President of Client…

Read More
Read More

Uncovering the Realities of Rare Disorders from the Patient’s Perspective

The world of rare diseases and the impact it has on countless lives is often underestimated. Rare…

Read More
Elderly lady with nurse
Read More

4 Ways to Enhance Care for Patients with Rare Diseases

The unique value of integrating the patient voice into the development process of therapies…

Read More
Read More

Using Evidence from the Exam Room to Shape RWE Strategy

Traditional methods for generating real-world evidence (RWE) from patient-physician conversations…

Read More
Read More

KJT Welcomes New VP of Qual, Marilisa Beatty

KJT is thrilled to announce the newest addition to our team, Marilisa Beatty, who will be joining…

Read More
Read More

Leveraging Patient-Provider Insights to Shape Commercial Strategy

In pharmaceutical and biotech market research, traditional methodologies to uncover insights from…

Read More
Read More

KJT Welcomes Ellen Gordon, PhD

KJT is thrilled to announce the newest addition to our Client Strategy team, Ellen Gordon, who will…

Let’s Take Research Further. Together.